Dynamiker SARS-CoV-2 Neutralization Antibody Rapid Test

RETURN TO MAIN SCREEN

Dynamiker SARS-CoV-2 Neutralization Antibody Rapid Test

Dynamiker Biotechnology (Tianjin) Co., Ltd.
Export this page in pdf
Disease target
SARS-CoV-2
Regulatory status
CE-IVD
Time to result
0.17
Assay target
Antibody (serological)
Test format
Rapid diagnostic test (strip or cassette)
Technology principle
Lateral Flow Assay
Target analyte
Total Antibody
Level of automation
Manual
Laboratory/Point-of-care
True Point of Care
Self-testing/Self-Collection
Intended for professional use only
Validated sample types
Plasma
serum
Connectivity
No
IMPACT OF SARS-COV-2 VARIANT:
Alpha - Unknown
Beta - Unknown
Gamma - Unknown
Manufacturer performance data
Sensitivity
95.74%
Specificity
99.15%